Evidence map›Paper›PMID 29303987›Full record

ArticleNutrients2018

Possible Mechanisms of the Prevention of Doxorubicin Toxicity by Cichoric Acid-Antioxidant Nutrient.

Agata Jabłońska-Trypuć, Rafał Krętowski, Monika Kalinowska, Grzegorz Świderski, Marzanna Cechowska-Pasko, Włodzimierz Lewandowski

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cardioprotective Potential ofCurrent pharmaceutical biotechnology · 2025
    Article
  6. Protective Potential ofInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exploring the Antioxidant Potential ofAntioxidants (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. International journal of environmental research and public health · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Agata Jabłońska-TrypućDepartment of Chemistry, Biology and Biotechnology, Faculty of Civil Engineering and Environmental Engineering, Białystok University of Technology, Wiejska 45E Street, 15-351 Białystok, Poland. a.jablonska@pb.edu.pl.ORCID 0000-0002-7711-3017
Rafał KrętowskiDepartment of Pharmaceutical Biochemistry, Medical University of Bialystok, 15-222 Białystok, Poland. r.kretowski@umb.edu.pl.ORCID 0000-0002-6548-5083
Monika KalinowskaDepartment of Chemistry, Biology and Biotechnology, Faculty of Civil Engineering and Environmental Engineering, Białystok University of Technology, Wiejska 45E Street, 15-351 Białystok, Poland. m.kalinowska@pb.edu.pl.
Grzegorz ŚwiderskiDepartment of Chemistry, Biology and Biotechnology, Faculty of Civil Engineering and Environmental Engineering, Białystok University of Technology, Wiejska 45E Street, 15-351 Białystok, Poland. g.swiderski@pb.edu.pl.
Marzanna Cechowska-PaskoDepartment of Pharmaceutical Biochemistry, Medical University of Bialystok, 15-222 Białystok, Poland. mapasko@gmail.com.
Włodzimierz LewandowskiDepartment of Chemistry, Biology and Biotechnology, Faculty of Civil Engineering and Environmental Engineering, Białystok University of Technology, Wiejska 45E Street, 15-351 Białystok, Poland. w.lewandowski@pb.edu.pl.
Bialystok University of Technology · PLMedical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin is the largest organ in the human body, and which protects organism against unfavorable external factors e.g., chemicals, environment pollutants, allergens, microorganisms, and it plays a crucial role in maintaining general homeostasis. It is also an important target of oxidative stress due to the activity of oxygen reactive species (ROS), which are constantly generated in the fibroblasts in response to exogenous or endogenous prooxidant agents. An example of such compound with proved prooxidant activity is Doxorubicin (DOX), which is an effective anticancer agent belongs in anthracycline antibiotic group. Increasingly frequent implementation of various strategies to reduce undesirable DOX side effects was observed. Very promising results come from the combination of DOX with dietary antioxidants from the polyphenol group of compounds, such as cichoric acid (CA) in order to lower oxidative stress level. The aim of this work was to evaluate the influence of CA combined with DOX on the oxidative stress parameters in fibroblasts, which constitute the main cells in human skin. We also wanted to examine anti-apoptotic activity of CA in fibroblasts treated with selected concentrations of DOX. Results obtained from the combination of DOX with CA revealed that CA exhibits cytoprotective activity against DOX-induced damage by lowering oxidative stress level and by inhibiting apoptosis. The present finding may indicate that CA may serve as antioxidative and anti-apoptotic agent, active against DOX-induced damage.

Indexed as

Antibiotics, AntineoplasticAntioxidantsApoptosisCaffeic AcidsCaspasesCell LineCytoprotectionDose-Response Relationship, DrugDoxorubicinFibroblastsGlutathioneHumansLipid PeroxidationOxidative StressReactive Oxygen SpeciesSkinAntibiotics, AntineoplasticAntioxidantsCaffeic AcidsCaspaseschicoric acidDoxorubicinGlutathioneReactive Oxygen SpeciesSuccinatesThiobarbituric Acid Reactive Substancescichoric aciddoxorubicinfibroblastsoxidative stressskin

Identifiers

PMID29303987
PMCPMC5793272
OpenAlexW2783707700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.